Home -
Products -
Others -
Other Targets -
PACAP-27 (6-27) (human, chicken, mouse, ovine, porcine, rat)
PACAP-27 (6-27) (human, chicken, mouse, ovine, porcine, rat)
CAS No. 136134-68-4
PACAP-27 (6-27) (human, chicken, mouse, ovine, porcine, rat)( ——— )
Catalog No. M40071 CAS No. 136134-68-4
PACAP (6-27) (human, ovine, rat) is a PACAP receptor antagonist that blocks the canine adrenal catecholamine response to exogenous vasoactive intestinal peptide (VIP). PACAP (6-27) (human, ovine, rat) has the potential to study cardiovascular and neurological diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 200 | In Stock |
|
| 10MG | 337 | In Stock |
|
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePACAP-27 (6-27) (human, chicken, mouse, ovine, porcine, rat)
-
NoteResearch use only, not for human use.
-
Brief DescriptionPACAP (6-27) (human, ovine, rat) is a PACAP receptor antagonist that blocks the canine adrenal catecholamine response to exogenous vasoactive intestinal peptide (VIP). PACAP (6-27) (human, ovine, rat) has the potential to study cardiovascular and neurological diseases.
-
DescriptionPACAP (6-27) (human, ovine, rat) is a PACAP receptor antagonist that blocks the canine adrenal catecholamine response to exogenous vasoactive intestinal peptide (VIP). PACAP (6-27) (human, ovine, rat) has the potential to study cardiovascular and neurological diseases.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorPACAP receptor.
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number136134-68-4
-
Formula Weight2638.15
-
Molecular FormulaC121H193N33O30S
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL (37.91 mM; )
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Coumarin-3-carboxyli...
The combination of Valproic acid with coumarin-3-carboxylic acid suppresses the proliferation and migration of lung cancer cells via EGFR/VEGFR2/c-Met-Akt-NF-κB signaling pathways.
-
GRGDSP TFA
GRGDSP, a synthetic linear RGD peptide, is an integrin inhibitor which can be used to modify the surface of cardiovascular implants such as vascular grafts to promote endothelialization.
-
Lupanine
Lupanine has a weak sedative effect on the central nervous system, interaction with specific drugs used for treatment of the CNS and for analgesic activity. Lupanine improves glucose homeostasis by influencing KATP-channels of pancreatic beta cells.
Cart
sales@molnova.com